[Congressional Bills 114th Congress]
[From the U.S. Government Publishing Office]
[H.R. 3537 Reported in House (RH)]

<DOC>





                                                 Union Calendar No. 615
114th CONGRESS
  2d Session
                                H. R. 3537

                      [Report No. 114-787, Part I]

   To amend the Controlled Substances Act to clarify how controlled 
    substance analogues are to be regulated, and for other purposes.


_______________________________________________________________________


                    IN THE HOUSE OF REPRESENTATIVES

                           September 17, 2015

Mr. Dent (for himself, Mr. Himes, Mr. Meehan, Mr. Dold, Mr. Tiberi, Mr. 
Costello of Pennsylvania, Mr. Hanna, Mr. Thompson of Pennsylvania, Mr. 
   Rogers of Kentucky, Mr. Murphy of Pennsylvania, Mr. Barletta, Ms. 
Norton, Mr. Lance, Mrs. Comstock, Mr. Katko, Ms. Ros-Lehtinen, and Mr. 
    Jolly) introduced the following bill; which was referred to the 
 Committee on Energy and Commerce, and in addition to the Committee on 
   the Judiciary, for a period to be subsequently determined by the 
  Speaker, in each case for consideration of such provisions as fall 
           within the jurisdiction of the committee concerned

                           September 26, 2016

  Additional sponsors: Mr. Rodney Davis of Illinois, Mr. Cuellar, Mr. 
Guthrie, Mr. Thornberry, Mr. Bishop of Michigan, Mr. King of New York, 
  Mr. Allen, Mr. Pierluisi, Ms. Kaptur, Mr. Peters, and Ms. Velazquez

                           September 26, 2016

   Reported from the Committee on Energy and Commerce with amendments
 [Strike out all after the enacting clause and insert the part printed 
                               in italic]

                           September 26, 2016

 The Committee on the Judiciary discharged; committed to the Committee 
 of the Whole House on the State of the Union and ordered to be printed
    [For text of introduced bill, see copy of bill as introduced on 
                          September 17, 2015]


_______________________________________________________________________

                                 A BILL


 
   To amend the Controlled Substances Act to clarify how controlled 
    substance analogues are to be regulated, and for other purposes.


 


    Be it enacted by the Senate and House of Representatives of the 
United States of America in Congress assembled,

SECTION 1. SHORT TITLE.

    This Act may be cited as the ``Dangerous Synthetic Drug Control Act 
of 2016''.

SEC. 2. TREATMENT OF CERTAIN DESIGNER DRUGS AS SCHEDULE I CONTROLLED 
              SUBSTANCES.

    (a) Cannabimimetic Agents.--Schedule I, as set forth in section 
202(c) of the Controlled Substances Act (21 U.S.C. 812(c)), is amended 
in subsection (d)(2)(B)--
            (1) in clause (xiv) by striking ``and'' at the end;
            (2) in clause (xv) by striking the period and inserting a 
        semicolon; and
            (3) by adding at the end the following:
                    ``(xvi) 2-(2-methylphenyl)-1-(1-pentyl-1H-indol-3-
                yl)ethanone (JWH-251);
                    ``(xvii) (1-butyl-1H-indol-3-yl)(4-
                methylnaphthalen-1-yl)methanone (4'-methyl JWH-073);
                    ``(xviii) 2-(3-methoxyphenyl)-1-(1-pentyl-1H-indol-
                3-yl)ethanone (JWH-302);
                    ``(xix) N-(adamantan-1-yl)-1-(5-fluoropentyl)-1H-
                indole-3-carboxamide (5F-APICA);
                    ``(xx) quinolin-8-yl 1-(5-fluoropentyl)-1H-indole-
                3-carboxylate (5F-PB-22);
                    ``(xxi) N-(1-amino-3-methyl-1-oxobutan-2-yl)-1-
                pentyl-1H-indazole-3-carboxamide (AB-PINACA);
                    ``(xxii) N-(naphthalen-1-yl)-1-pentyl-1H-indole-3-
                carboxamide (MN-24);
                    ``(xxiii) (1-(5-fluoropentyl)-1H-indazol-3-
                yl)(naphthalen-1-yl)methanone (THJ-2201);
                    ``(xxiv) N-(1-amino-3,3-dimethyl-1-oxobutan-2-yl)-
                1-pentyl-1H-indazole-3-carboxamide (ADBICA);
                    ``(xxv) methyl 2-(1-(5-fluoropentyl)-1H-indazole-3-
                carboxamido)-3-methylbutanoate (5F-AMB); and
                    ``(xxvi) methyl 2-(1-(cyclohexylmethyl)-1H-
                indazole-3-carboxamido)-3-methylbutanoate (MA-
                CHMINACA).''.
    (b) Synthetic Opioids.--Schedule I, as set forth in section 202(c) 
of the Controlled Substances Act (21 U.S.C. 812(c)), is amended in 
subsection (a) by adding at the end the following:
            ``(43) Butyryl fentanyl.
            ``(44) beta-Hydroxythiofentanyl.
            ``(45) Acetyl fentanyl.''.
    (c) Other Drugs.--Schedule I, as set forth in section 202(c) of the 
Controlled Substances Act (21 U.S.C. 812(c)), is amended in subsection 
(c) by adding at the end the following:
            ``(29) 1-(naphthalen-1-yl)-2-(pyrrolidin-1-yl)pentan-1-one 
        (a-naphyrone).
            ``(30) 1-(2,3-dihydrobenzofuran-5-yl)propan-2-amine (5-
        APDB).
            ``(31) 1-(2,3-dihydrobenzofuran-6-yl)propan-2-amine (6-
        APDB).
            ``(32) 6,7-dihydro-5H-indeno[5,6-d][1,3]dioxol-6-amine 
        (MDAI).
            ``(33) 5-iodo-2,3-dihydro-1H-inden-2-amine (5-IAI).
            ``(34) 1-(4-bromofuro[2,3-f]benzofuran-8-yl)propan-2-amine 
        (bromo-dragonfly).
            ``(35) 1-(4-chloro-2,5-dimethoxyphenyl)propan-2-amine 
        (DOC).
            ``(36) 1-(4-ethoxy-2,5-dimethoxyphenyl)propan-2-amine 
        (MEM).''.
            Amend the title so as to read: ``A bill to amend the 
        Controlled Substances Act to add certain synthetic substances 
        to schedule I, and for other purposes.''.
                                                 Union Calendar No. 615

114th CONGRESS

  2d Session

                               H. R. 3537

                      [Report No. 114-787, Part I]

_______________________________________________________________________

                                 A BILL

   To amend the Controlled Substances Act to clarify how controlled 
    substance analogues are to be regulated, and for other purposes.

_______________________________________________________________________

                           September 26, 2016

   Reported from the Committee on Energy and Commerce with amendments

                           September 26, 2016

 The Committee on the Judiciary discharged; committed to the Committee 
 of the Whole House on the State of the Union and ordered to be printed